ImageneBio IMA Cash Flow Statement (2020-2026)

NASDAQ IMA
$3.72 -0.09 (-2.36%)
As of: Nov 11, 2026 · 3:56 PM EST
Reported Financials

ImageneBio Quarterly Cash Flow Statement

Periods 27 quarters
Latest Sep 2026

ImageneBio reported cash from operations of -$9.52M and free cash flow of -$9.52M for the quarter ended Sep 2026, up 55.7% year over year. This cash flow statement covers 27 quarters of results from Mar 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
2.80M-16.84M-20.49M-17.34M-14.10M-14.22M-17.12M-17.34M-19.49M-16.15M-13.73M-1.88M-17.48M-6.08M-7.59M-24.78M-6.91M-10.62M-10.18M-15.62M
Depreciation and DepletionDep. & Depletion
0.16M0.18M0.15M0.21M0.21M0.23M0.24M0.24M0.31M0.22M0.09M0.09M0.10M0.09M0.09M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.16M0.18M0.15M0.21M0.21M0.23M0.24M0.24M0.31M0.22M0.09M0.09M0.02M0.00M0.00M0.00M0.39M
Share-based CompensationStock Comp.
1.58M1.90M1.96M1.81M1.86M2.00M1.88M2.00M1.76M2.00M1.28M1.02M5.30M0.06M15.28M0.05M0.88M0.91M1.67M
Gains from Sales and DivestituresGains Divest
-0.10M-1.19M1.19M
Gains from Investment SecuritiesGains Investment
-0.48M0.27M
Asset Writedowns and ImpairmentWritedown
0.74M
Other non-cash itemsOther Non-Cash
0.31M0.35M0.34M0.36M0.28M0.34M0.34M0.47M0.56M0.45M0.46M-0.59M1.74M0.20M0.36M0.26M-0.17M0.17M0.18M0.18M
Change in Working Capital
Change in ReceivablesChange Receivables
0.30M0.31M0.32M0.33M0.34M0.35M0.36M0.63M0.75M
Change in Account PayablesChange Payables
0.46M0.00M0.95M-1.16M-0.09M0.67M-0.99M-0.67M-1.88M-0.16M-0.50M-1.58M1.07M1.43M-0.46M-3.14M-0.64M-0.87M0.41M-0.19M
Change in Accrued ExpensesChange Accrued Exp.
1.70M-1.52M0.83M3.51M-0.59M-2.92M0.91M-3.30M-2.35M-3.76M-1.72M4.76M-1.75M-0.31M0.29M-9.93M0.85M-0.49M-0.08M2.15M
Change in Other Operating AssetsOther Assets Change
-0.15M0.17M2.66M-2.11M-0.56M-0.31M0.46M-0.99M0.83M0.37M-2.63M2.37M-2.89M1.79M4.41M-1.36M-8.81M3.31M-0.32M-2.89M
Change in Other Operating LiabilitiesOther Liabilities Change
-20.22M-3.38M-0.38M-6.40M-5.45M-5.66M-2.36M-1.82M-1.32M-0.98M-0.58M1.87M-3.41M-0.73M-0.09M-0.51M0.68M-0.55M-0.63M-0.59M
Other Working Capital ChangesOther WC Changes
-20.07M-3.55M-3.04M-4.30M-4.90M-5.35M-2.82M-0.83M-2.15M-1.35M2.04M-0.50M-0.52M-2.53M-4.50M0.85M9.49M-3.86M-0.31M2.30M
Cash from OperationsCash from Ops.
-13.37M-19.78M-19.45M-17.22M-17.66M-19.78M-18.14M-20.00M-21.82M-18.30M-12.50M12.96M-28.16M-7.23M-11.90M-21.50M-7.22M-14.80M-9.07M-9.52M
Investing Activities
Capital ExpendituresCapex
0.55M0.03M0.04M1.13M0.23M0.15M0.26M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.06M0.19M0.62M-0.43M
Change in Property, Plant and EquipmentChange in PP&E
-0.55M-0.03M-0.04M-1.13M-0.23M-0.15M-0.26M0.06M0.19M0.62M-0.43M
Purchase of InvestmentsInvestments Purchased
166.02M8.98M14.87M26.48M41.73M5.32M18.17M24.84M62.30M9.97M-72.27M88.30M1.49M-11.88M10.94M8.00M5.67M
Sale and Maturity of InvestmentsInvestments Sold
51.78M37.21M31.07M28.00M50.06M45.48M13.50M13.70M-17.05M50.31M2.25M7.55M10.50M7.65M5.29M
Other Investing Activities (as filed)Other investing (as filed)
9.79M
Cash from Investing ActivitiesCash from Investing
-0.55M-166.05M20.49M35.78M10.50M-10.81M22.68M31.89M20.38M-48.74M3.92M55.84M-45.92M-4.45M-1.36M-0.44M-0.35M-0.39M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
7.50M
Net Long-Term Debt Issued (Repaid)Net LT Debt
7.50M
Net Debt Issuances and RepaymentsNet Debt Issuance
7.50M
Change in Capital Stock
Common Stock IssuedStock Issued
0.24M0.50M0.58M0.02M0.00M-0.11M0.05M0.04M28.05M0.14M
Net Shares Issued and RepurchasedNet Shares Issued
0.24M0.50M0.58M0.02M0.00M-0.11M0.05M0.04M28.05M0.14M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.24M0.50M0.58M0.02M0.00M-0.11M0.05M0.04M28.05M0.14M
Other financing activities (as filed)
-0.59M-0.02M-1.98M2.00M54.63M-0.06M
Cash from Financing ActivitiesCash from Financing
0.24M0.50M0.58M0.02M0.00M38.92M0.06M6.91M0.03M13.02M122.42M-3.24M28.05M0.08M
Additional items
Exchange Rate EffectFX Effect
-0.03M0.00M-0.01M0.66M-0.05M
Change in Cash
-13.68M-185.34M1.61M18.59M-7.16M-30.59M41.54M50.82M-1.38M-67.04M-8.58M68.92M-74.20M-7.20M1.10M97.14M-8.63M-18.48M18.63M-9.82M
Ending Cash Balance
233.09M47.75M49.36M67.95M60.79M30.20M71.74M122.56M15.32M54.13M45.55M8.73M12.12M4.92M6.02M103.16M94.53M76.05M94.68M84.85M
Free Cash FlowFCF
-13.92M-19.82M-19.49M-18.35M-17.89M-19.94M-18.14M-20.00M-22.08M-18.30M-12.50M12.96M-28.16M-7.23M-11.90M-21.50M-7.22M-14.80M-9.07M-9.52M
Net Cash FlowNCF
-13.68M-185.34M1.61M18.59M-7.16M-30.59M4.54M50.82M-1.38M-67.04M-8.58M68.80M-67.18M-7.20M1.12M96.48M-8.58M-18.48M18.63M-9.82M
Income Taxes PaidTaxes Paid
0.22M0.01M

ImageneBio Cash Flow Statement API

Pull ImageneBio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY